Buy & Sell abrdn Income Credit Strategies Fund (ACP) – abrdn Income Credit Strategies Fund Price Today
Aura AI Summary
Key Stats
- $672.52MMarket Cap
- FinancialsSector
- -12.41%3M Drawdown
- -Enterprise Value
- 17.35%Dividend Yield
- 91 daysTypical Hold Time
abrdn Income Credit Strategies Fund (ACP) is currently valued at a market capitalization of $672.52M. Over the past 52 weeks, abrdn Income Credit Strategies Fund has traded between a low of $5.01 and a high of $5.98, highlighting its annual price range. Over the past three months, abrdn Income Credit Strategies Fund has recorded a drawdown of -12.41%, reflecting recent price volatility. abrdn Income Credit Strategies Fund offers a dividend yield of 17.35%, with the most recent dividend of $0.08 paid on 22 Apr 26. On average, investors hold abrdn Income Credit Strategies Fund for approximately 91 days, indicating typical investor behavior on the platform.
About abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Most Recent News
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...